Ask AI
ProCE Banner Activity

Integrating the Latest Evidence for Immunotherapy Into Community Care for Locally Advanced Head and Neck Cancer: Best Practices for the Multidisciplinary Team

Slideset

Downloadable slides featuring key data on current and emerging immunotherapies as well as guideline-recommended management strategies for locally advanced head and neck cancers.

Released: April 20, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by educational grants from Coherus BioSciences, Inc. and Merck Sharp & Dohme LLC.

Coherus BioSciences, Inc.

Merck Sharp & Dohme LLC

Target Audience

This activity is intended for oncologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals caring for patients with locally advanced head and neck cancers.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify patients with locally advanced HNC who are most likely to benefit from immunotherapy using predictive and/or prognostic biomarkers

  • Recommend personalized treatment strategies that leverage immunotherapy for patients with locally advanced HNC, guided by the latest clinical evidence, expert recommendations, and patient factors

  • Implement collaborative care approaches across multidisciplinary teams to enhance patient-centered management of locally advanced HNC, including effective care coordination, supportive care, and patient/caregiver education

  • Manage immune-related adverse events associated with immunotherapy-based treatments to maximize quality of life and clinical outcomes in each patient with locally advanced HNC